注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Lyra Therapeutics Inc是一家臨床階段的治療公司,專注於開發和商業化用於患者局部治療的新型綜合藥物和遞送解決方案。該公司的治療管道針對耳朵、鼻子和喉嚨通道深處的組織,旨在提供持續的藥物治療。該公司的技術平台XTreo旨在通過單次給藥,在持續時間內將藥物精確、一致地直接輸送到受影響的組織。該公司的候選產品LYR-210和LYR-220是生物可吸收聚合物基質,旨在通過簡短、非侵入性的就診程序進行給藥,旨在為鼻竇通道提供長達六個月的連續藥物治療。治療慢性鼻竇炎(CRS)。LYR-210和LYR-220中的治療藥物是糠酸莫米松。LYR-220是一種針對有和沒有鼻息肉的CRS患者的研究性療法。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
W. Bradford Smith | 66 | 2019 | Independent Director |
Gary M. Ansel | - | - | Member of Medical Advisory Board |
Martin Schillinger | - | - | Member of Medical Advisory Board |
Elazer R. Edelman | 65 | - | Member of Scientific Advisory Board |
I. Baumgartner | - | - | Member of Medical Advisory Board |
Robert S. Langer | 73 | 2006 | Member of Scientific Advisory Board |
George M. Whitesides | 83 | 2006 | Member of Scientific Advisory Board |
Renu Virmani | - | - | Member of Scientific Advisory Board |
Michael D. Dake | - | - | Member of Medical Advisory Board |
Mark Saltzman | - | - | Member of Scientific Advisory Board |
Konstantin Poukalov | 38 | 2020 | Independent Director |
Michael Seth Altman | 40 | 2018 | Independent Director |
William A. Gray | - | - | Member of Medical Advisory Board |
Robert S. Schwartz | - | - | Member of Scientific Advisory Board |
James Morley Anderson | 81 | - | Member of Scientific Advisory Board |
Mahmood K. Razavi | - | - | Member of Medical Advisory Board |
Stephen L. Hilbert | - | - | Member of Scientific Advisory Board |
Nancy L. Snyderman | 69 | 2020 | Independent Director |
James R. Tobin | 77 | 2022 | Lead Independent Director |
Edward Thomas Anderson | 70 | 2019 | Independent Director |
Maria Palasis | 58 | 2015 | CEO, President & Director |
Harlan W. Waksal | 70 | 2022 | Executive Chairman |
C. Ann Merrifield | 72 | 2019 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核